Synthesis and biological evaluation of 5-nitropyrimidine analogs with azabicyclic substituents as GPR119 agonists

Bioorganic & Medicinal Chemistry Letters
2013.0

Abstract

5-Nitropyrimidine analogs substituted with conformationally restricted azabicyclic amines and alcohols were prepared and evaluated their agonistic activity against human GPR119. The analogs bearing endo-azabicyclic amines and alcohols (7, 8, 11, and 12) exhibited full agonistic activities while the analogs with exo-azabicyclic amines and alcohols were proved as partial agonists (9, 10, 13, and 14) regardless of their EC(50) values. 5-Nitropyrimidine analogs with (2-fluoro-4-methylsulfonyl)phenylamino group (8, 10, 12, 14) showed more potent GPR119 activation activities than the analogs without fluorine in all cases (7, 9, 11, 13).

Knowledge Graph

Similar Paper

Synthesis and biological evaluation of 5-nitropyrimidine analogs with azabicyclic substituents as GPR119 agonists
Bioorganic & Medicinal Chemistry Letters 2013.0
Novel 5-nitropyrimidine derivatives bearing endo-azabicyclic alcohols/amines as potent GPR119 agonists
Bioorganic & Medicinal Chemistry 2017.0
Synthesis and biological evaluation of pyrimidine derivatives with diverse azabicyclic ether/amine as novel GPR119 agonist
Bioorganic & Medicinal Chemistry Letters 2017.0
Synthesis and biological evaluation of novel 2,4-disubstituted quinazoline analogues as GPR119 agonists
Bioorganic & Medicinal Chemistry 2013.0
Design and synthesis of novel pyrimido[5,4-d]pyrimidine derivatives as GPR119 agonist for treatment of type 2 diabetes
Bioorganic & Medicinal Chemistry 2018.0
Design and biological evaluation of tetrahydropyridine derivatives as novel human GPR119 agonists
Bioorganic & Medicinal Chemistry Letters 2020.0
Fluorinated pyrazole acids are agonists of the high affinity niacin receptor GPR109a
Bioorganic & Medicinal Chemistry Letters 2007.0
5-N,N-Disubstituted 5-aminopyrazole-3-carboxylic acids are highly potent agonists of GPR109b
Bioorganic & Medicinal Chemistry Letters 2009.0
Discovery of pyrazolyl propionyl cyclohexenamide derivatives as full agonists for the high affinity niacin receptor GPR109A
Bioorganic & Medicinal Chemistry Letters 2010.0
Discovery of pyrazolopyrimidines as the first class of allosteric agonists for the high affinity nicotinic acid receptor GPR109A
Bioorganic & Medicinal Chemistry Letters 2008.0